Skip to content

Search

Now We Are Five - ORIGINS celebrates milestone

ORIGINS is celebrating its first five-year-old 'graduates'.

Benefits for ORIGINS families

ORIGINS is an interventional cohort study, meaning participants receive timely feedback and an action plan to address any potential abnormalities.

Medical History & Conditions

The impact of familial and childhood health conditions on health later in life.

Sub-projects

As well as ORIGINS long-term core research, there are a number of clinical trials, early interventions and shorter-term research studies that sit within ORIGINS. Known as sub-projects, these studies look at multiple aspects of child and family health and development.

Available data & biological samples

ORIGINS is collecting data from multiple sources from the mother, infant and partner at multiple timepoints from gestation through to five years of age.

Biobank funding supports valuable research resources

Four The Kids Research Institute Australia-based biobanks which underpin a range of cancer, respiratory and early life research have received more than $450,000 in funding.

Papers and Publications

Publications, papers and findings coming out of ORIGINS and its sub-projects

ORIGINS sub-project awarded substantial Channel 7 Telethon Trust grant to support disadvantaged children

STARS for Kids, a sub-project of ORIGINS, received a three-year grant to advance the development of a scalable, online, tiered model of care to better support disadvantaged communities, where 20-25 per cent of children are entering school developmentally vulnerable.

Funding boost for ORIGINS child and family health research

ORIGINS is celebrating a substantial funding increase for its world-class research into child and family health and wellbeing.

New evidence shows timely introduction of peanuts and eggs reduces allergy risks

Families who introduce peanut butter and eggs to their baby’s diet at around six months of age can significantly reduce the chances of them developing a life-threatening allergy, according to a new study published in the Journal of Allergy and Clinical Immunology – In Practice.